Compared efficacy of clopidogrel and ticagrelor in treating acute coronary syndrome: a meta-analysis
Abstract Background & Aims Ticagrelor has been acknowledged as a new oral antagonist of P2Y12-adenosine diphosphate receptor, as a strategy with more rapid onset as well as more significant platelet inhibition function in acute coronary syndrome (ACS) patients. The clinical benefit of ticagrelor com...
Kaydedildi:
| Asıl Yazarlar: | , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2018-11-01
|
| Seri Bilgileri: | BMC Cardiovascular Disorders |
| Konular: | |
| Online Erişim: | http://link.springer.com/article/10.1186/s12872-018-0948-4 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|